Cargando…
Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
Gastric cancer (GC) is still one of the most aggressive cancers with a few targetable alterations and a dismal prognosis. A liquid biopsy allows for identifying and analyzing the DNA released from tumor cells into the bloodstream. Compared to tissue-based biopsy, liquid biopsy is less invasive, requ...
Autores principales: | Grizzi, Giulia, Salati, Massimiliano, Bonomi, Maria, Ratti, Margherita, Holladay, Lauren, De Grandis, Maria Caterina, Spada, Daniele, Baiocchi, Gian Luca, Ghidini, Michele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254023/ https://www.ncbi.nlm.nih.gov/pubmed/37298371 http://dx.doi.org/10.3390/ijms24119421 |
Ejemplares similares
-
Krukenberg Tumor Related to Gallbladder Cancer in a Young Woman: A Case Report and Review of the Literature
por: Grizzi, Giulia, et al.
Publicado: (2023) -
Development and Multicenter Validation of a Novel Immune-Inflammation-Based Nomogram to Predict Survival in Western Resectable Gastric and Gastroesophageal Junction Adenocarcinoma (GEA): The NOMOGAST
por: Salati, Massimiliano, et al.
Publicado: (2022) -
Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
por: Grizzi, Giulia, et al.
Publicado: (2023) -
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
por: Ratti, Margherita, et al.
Publicado: (2020) -
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?
por: Khakoo, Shelize, et al.
Publicado: (2021)